| 000 | 01813 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516051909.0 | ||
| 264 | 0 | _c20120524 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1534-4681 | ||
| 024 | 7 |
_a10.1245/s10434-011-2005-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVerhage, Roy J J | |
| 245 | 0 | 0 |
_aRisk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinoma. _h[electronic resource] |
| 260 |
_bAnnals of surgical oncology _cFeb 2012 |
||
| 300 |
_a684-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aEsophagectomy _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPerioperative Care |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThromboembolism _xetiology |
| 700 | 1 | _avan der Horst, Sylvia | |
| 700 | 1 | _avan der Sluis, Pieter C | |
| 700 | 1 | _aLolkema, Martijn P J K | |
| 700 | 1 | _avan Hillegersberg, Richard | |
| 773 | 0 |
_tAnnals of surgical oncology _gvol. 19 _gno. 2 _gp. 684-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1245/s10434-011-2005-8 _zAvailable from publisher's website |
| 999 |
_c21081785 _d21081785 |
||